Translational Bioinformatics Embraces Big Data

 

 Permissions and Reprints

Summary

We review the latest trends and major developments in translational bioinformatics in the year 2011-2012. Our emphasis is on highlighting the key events in the field and pointing at promising research areas for the future. The key take-home points are:

• Translational informatics is ready to revolutionize human health and healthcare using large-scale measurements on individuals.

• Data–centric approaches that compute on massive amounts of data (often called “Big Data”) to discover patterns and to make clinically relevant predictions will gain adoption.

• Research that bridges the latest multimodal measurement technologies with large amounts of electronic healthcare data is increasing; and is where new breakthroughs will occur.

• References

• 1 Shah NH, Tenenbaum JD. The coming age of data-driven medicine: Translational Bioinformatics’ next frontier. J Am Med Inform Assoc 2012; Jun 1; 19 e1 e2-e4.
  CrossrefPubMedGoogle Scholar
• 2 Altman RB, Miller KS. 2010 translational bioinformatics year in review. J Am Med Inform Assoc 2011; 18 (04) 358-66.
  CrossrefPubMedGoogle Scholar
• 3 Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature 2011; 470 7333 204-13.
  CrossrefPubMedGoogle Scholar
• 4 Liu M, Wu Y, Chen Y, Sun J, Zhao Z, Chen XW. et al. Large-scale Prediction of Adverse Drug Reactions by Integrating Chemical, Biological, and Phenotypic Properties of Drugs. J Am Med Inform Assoc 2012; Jun 1; 19 e1 e28-e35.
  CrossrefPubMedGoogle Scholar
• 5 Russu A, Malovini A, Puca AA, Bellazzi R. Stochastic model search with binary outcomes for Genome-Wide Association Studies. J Am Med Inform Assoc 2012; Jun 1; 19 e1 e13-e20.
  CrossrefPubMedGoogle Scholar
• 6 Morgan AA, Chen R, Butte AJ. Clinical utility of sequence-based genotype compared with that derivable from genotyping arrays. J Am Med Inform Assoc 2012; Jun 1; 19 e1 e21-e27.
  CrossrefPubMedGoogle Scholar
• 7 Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B. et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011; 13 (03) 255-62.
  CrossrefPubMedGoogle Scholar
• 8 Mayer AN, Dimmock DP, Arca MJ, Bick DP, Verbsky JW, Worthey EA. et al. A timely arrival for genomic medicine. Genet Med 2011; 13 (03) 195-6.
  CrossrefPubMedGoogle Scholar
• 9 Trelles O, Prins P, Snir M, Jansen RC. Big data, but are we ready?. Nat Rev Genet 2011; 12 (03) 224.
  PubMedGoogle Scholar
• 10 Schadt EE, Linderman MD, Sorenson J, Lee L, Nolan GP. Cloud and heterogeneous computing solutions exist today for the emerging big data problems in biology. Nat Rev Genet 2011; 12 (03) 224.
  PubMedGoogle Scholar
• 11 Weiss R. Obama Administration Unveils “Big Data” Initiative: Announces $200 million in new R&D Investments. Washington D.C: O.o.S.a.T. Policy, Executive Off ice of the President; 2012: 1-4.
  Google Scholar
• 12 Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM, Weston N. et al. Electronic Medical Records for Genetic Research: Results of the eMERGE Consortium. Sci Transl Med 2011; 03 (79) 79re1.
  PubMedGoogle Scholar
• 13 Kho AN, Hayes MG, Rasmussen-Torvik L, Pacheco JA, Thompson WK, Armstrong LL. et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. JAm Med Inform Assoc 2012; 19 (02) 212-8.
  PubMedGoogle Scholar
• 14 Wei WQ, Leibson CL, Ransom JE, Kho AN, Caraballo PJ, Chai HS. et al. Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. J Am Med Inform Assoc 2012; 19 (02) 219-24.
  CrossrefPubMedGoogle Scholar
• 15 Halevy A, Norvig P, Pereira F. The unreasonable effectiveness of data. IEEE Intelligent Systems 2009; 24 (02) 8-12.
  PubMedGoogle Scholar
• 16 Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE. et al. Clinical assessment incorporating a personal genome. Lancet 2010; 375 9725 1525-35.
  CrossrefPubMedGoogle Scholar
• 17 Samani NJ, Tomaszewski M, Schunkert H. The personal genome—the future of personalised medicine?. Lancet 2010; 375 9725 1497-8.
  CrossrefPubMedGoogle Scholar
• 18 Harpaz R, Dumouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel Data Mining Methodologies for Adverse Drug Event Discovery and Analysis. Clin Pharmacol Ther. 2012 in press.
  PubMedGoogle Scholar
• 19 Lussier YA, Chen JL. The emergence of genome-based drug repositioning. Sci Transl Med 2011; 03 (96) 96ps35.
  PubMedGoogle Scholar
• 20 Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmaco-epidemiol Drug Saf 2009; 18 (06) 427-36.
  CrossrefPubMedGoogle Scholar
• 21 Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf 2002; 25 (06) 381-92.
  CrossrefPubMedGoogle Scholar
• 22 Weiss-Smith S, Deshpande G, Chung S, Gogolak V. The FDA drug safety surveillance program: adverse event reporting trends. Arch Intern Med 2011; 171 (06) 591-3.
  CrossrefPubMedGoogle Scholar
• 23 Norén GN, Sundberg R, Bate A, Edwards IR. A statistical methodology for drug-drug interaction surveillance. Stat Med 2008; 27 (16) 3057-70.
  CrossrefPubMedGoogle Scholar
• 24 Tatonetti NP, Denny JC, Murphy SN, Fernald GH, Krishnan G, Castro V. et al. Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels. Clin Pharmacol Ther 2011; 90 (01) 133-42.
  CrossrefPubMedGoogle Scholar
• 25 Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med 2012; Mar 14; 04 (125) 125ra31.
  PubMedGoogle Scholar
• 26 Cami A, Arnold A, Manzi S, Reis B. Predicting adverse drug events using pharmacological network models. Sci Transl Med 2011; 03 (114) 114ra127.
  PubMedGoogle Scholar
• 27 Pouliot Y, Chiang AP, Butte AJ. Predicting adverse drug reactions using publicly available PubChem BioAssay data. Clin Pharmacol Ther 2011; 90 (01) 90-9.
  CrossrefPubMedGoogle Scholar
• 28 Vilar S, Harpaz R, Chase HS, Costanzi S, Rabadan R, Friedman C. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis. J Am Med Inform Assoc 2011; 18 Suppl 1: i73-80.
  PubMedGoogle Scholar
• 29 Liu Y, LePendu P, Iyer S, Shah NH. Using Temporal Patterns in Medical Records to Discern Adverse Drug Events from Indications. In: AMIA Summit on Clinical Research Informatics. 2012. San Francisco: AMIA.;
  Google Scholar
• 30 Lependu P, Iyer SV, Fairon C, Shah NH. Annotation Analysis for Testing Drug Safety Signals. J Biomed Semantics 2012; 3 Suppl 1: pS5.
  PubMedGoogle Scholar
• 31 Brownstein JS, Sordo M, Kohane IS, Mandl KD. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2007; 02 (09) e840.
  CrossrefPubMedGoogle Scholar
• 32 Harpaz R, Chase H, Friedman C. Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics 2010; 11 Suppl 9: S7.
  PubMedGoogle Scholar
• 33 Dore D, Seeger J, Arnold KChan. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin 2009; 25 (04) 1019-27.
  CrossrefPubMedGoogle Scholar
• 34 Nadkarni P. Drug safety surveillance using de-identified EMR and claims data: issues and challenges. J Am Med Inform Assoc 2010; 17 (06) 671-4.
  CrossrefPubMedGoogle Scholar
• 35 Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT. et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007; 16 (12) 1275-84.
  CrossrefPubMedGoogle Scholar
• 36 Shetty KD, Dalal S. Using information mining of the medical literature to improve drug safety. J Am Med Inform Assoc 2011; 18 (05) 668-74.
  CrossrefPubMedGoogle Scholar
• 37 Chee BW, Berlin R, Schatz B. Predicting adverse drug events from personal health messages. AMIA Annu Symp Proc 2011; 2011: 217-26.
  PubMedGoogle Scholar
• 38 Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 2011; 07: 496.
  PubMedGoogle Scholar
• 39 Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A. et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011; 03 (96) 96ra77.
  PubMedGoogle Scholar
• 40 Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP. et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 2011; 03 (96) 96ra76.
  PubMedGoogle Scholar
• 41 Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, Turnbaugh PJ. et al. Detecting Novel Associations in Large Data Sets. Science 2011; 334 6062 1518-24.
  CrossrefPubMedGoogle Scholar
• 42 Sobek M, Cleveland L, Flood S, Hall PK, King ML, Ruggles S. et al. Big Data: Large-Scale Historical Infrastructure from the Minnesota Population Center. Hist Methods 2011; 44 (02) 61-8.
  CrossrefPubMedGoogle Scholar
• 43 Fox B. Using big data for big impact. How predictive modeling can affect patient outcomes. Health Manag Technol 2012; 33 (01) 32.
  PubMedGoogle Scholar
• 44 Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R. et al. Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes. Cell 2012; 148 (06) 1293-1307.
  CrossrefPubMedGoogle Scholar
• 45 Frankovich J, Longhurst CA, Sutherland SM. Evidence-based medicine in the EMR era. N Engl J Med 2011; 365 (19) 1758-9.
  CrossrefPubMedGoogle Scholar
• 46 Tung JY, Do CB, Hinds DA, Kiefer AK, Macpherson JM, Chowdry AB. et al. Efficient replication of over 180 genetic associations with self-reported medical data. PLoS ONE 2011; 06 (08) e23473.
  CrossrefPubMedGoogle Scholar
• 47 Roque FS, Jensen PB, Schmock H, Dalgaard M, Andreatta M, Hansen T. et al. Using electronic patient records to discover disease correlations and stratify patient cohorts. Plos Comput Biol 2011; 07 (08) e1002141.
  CrossrefPubMedGoogle Scholar
• 48 FFrost J, Okun S, Vaughan T, Heywood J, Wicks P. Patient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMe. J Med Internet Res 2011; 13 (01) e6.
  CrossrefPubMedGoogle Scholar
• 49 Wicks P, Vaughan TE, Massagli MP, Heywood J. Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nature Biotechnol 2011; 29 (05) 411-4.
  CrossrefPubMedGoogle Scholar
• 50 Hays J, Efros AA. Scene completion using millions of photographs. Commun ACM 2008; 51 (10) 87-94.
  PubMedGoogle Scholar
• 51 Bringardner J. Winning the Lawsuit: Data Miners Dig for Dirt. Wired Magazine. 2008 (16-07)
  PubMedGoogle Scholar
• 52 Michel JB, Shen YK, Aiden AP, Veres A, Gray MK. Google Books Team. et al. Quantitative analysis of culture using millions of digitized books. Science 2011; 331 6014 176-82.
  CrossrefPubMedGoogle Scholar
• 53 National Research Council, U.S.C.o.A.F. f.D.a.N.T.o.D. Toward precision medicine building a knowledge network for biomedical research and a new taxonomy of disease. 2011 Available from: http://www.worldcat.org/isbn/0309222222
  PubMedGoogle Scholar